XML 11 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Details Textual) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended
May 31, 2014
May 31, 2013
May 31, 2014
May 31, 2013
May 31, 2014
Xenogenics Corporation [Member]
May 31, 2013
Xenogenics Corporation [Member]
May 31, 2014
Xenogenics Corporation [Member]
May 31, 2013
Xenogenics Corporation [Member]
Feb. 03, 2011
Xenogenics Corporation [Member]
Oct. 31, 2010
Xenogenics Corporation [Member]
Jan. 15, 2014
Director [Member]
May 31, 2014
Director [Member]
Jan. 15, 2014
Employee [Member]
Dec. 02, 2012
Equity Incentive Plan 2004 [Member]
Dec. 02, 2011
Equity Incentive Plan 2004 [Member]
Jul. 11, 2011
Equity Incentive Plan 2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                 8,000,000 5,000,000       1,500,000 1,500,000 70,974,213
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     25,074,710       0       4,600,000   2,074,710      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 0.0008       $ 0       $ 0.0008   $ 0.0008      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                       $ 0.0007        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate                       1.68%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                       140.00%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Term                       5 years        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                       0.00%        
Allocated Share-based Compensation Expense $ 12,027 $ 4,406 $ 21,935 $ 8,812 $ 11,058 $ 18,647 $ 43,162 $ 114,109                
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options $ 23,000   $ 23,000                          
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition     1 year                          
Closing Price Share $ 0.0008   $ 0.0008                          
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent             100.00%                  
Share-based Compensation Arrangement by Share-based Payment Award, Original Terms of Plan             A 10% stockholder shall not be granted an ISO unless the exercise price of such option is at least 110% of the fair market value of Xenogenics common stock on the date of the grants and the option is not exercisable after the expiration of five years from the date of the grant.                  
Share-based Compensation Arrangement by Share-based Payment Award, Option, Maximum Term             10 years